ARTICLE | Company News
Matritech other research news
July 3, 1995 7:00 AM UTC
NMPS (Cambridge, Mass.) announced it has confirmed the DNA sequence of the gene for the cancer-specific marker PC-1.
The company intends to develop antibodies to market for diagnostic use. Therapeutics based on the nuclear matrix protein also will be developed. ...